Rosiglitazone reduces insulin resistance, an underlying defect of type 2 diabetes.
Official product site with information primarily intended for diabetics. Includes patient and prescribing information.
Features information about dosage, usage, warnings, and side effects.
Diabetes News : FDA Issues Safety Alert on Avandia
Potential safety issue related to Avandia (rosiglitazone), a drug approved to treat type 2 diabetes. (May 21, 2007)
Last update:March 12, 2015 at 11:06:05 UTC